Increased risk of immune checkpoint inhibitor-induced type 1 diabetes mellitus with the new approved 6-week scheme of pembrolizumab in patients with melanoma?
| Image |  |
|---|---|
| Description | scientific article published on 02 September 2020 |
| Author/s |
author: Axel Hauschild |
| Publication date | September 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |